Moeslein v. Commonwealth, State Board of Pharmacy

432 A.2d 295, 60 Pa. Commw. 574, 1981 Pa. Commw. LEXIS 1605
CourtCommonwealth Court of Pennsylvania
DecidedJuly 17, 1981
DocketAppeal, 33 C.D. 1980
StatusPublished
Cited by4 cases

This text of 432 A.2d 295 (Moeslein v. Commonwealth, State Board of Pharmacy) is published on Counsel Stack Legal Research, covering Commonwealth Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Moeslein v. Commonwealth, State Board of Pharmacy, 432 A.2d 295, 60 Pa. Commw. 574, 1981 Pa. Commw. LEXIS 1605 (Pa. Ct. App. 1981).

Opinion

Opinion by

Judge MacPhail,

William Moeslein (Petitioner) is appealing an order of the State Board of Pharmacy (Board) which revoked Petitioner’s pharmacist license.

The facts of this case are not in dispute. Petitioner has been a practicing licensed pharmacist in Pennsylvania since 1971. On February 28,. 1979, the Board cited Petitioner for violations of the Pharmacy Act, 1 the regulations promulgated thereunder at 49 Pa. Code §27.18 (u) and several sections of The Controlled *576 Substance, Drug, Device and Cosmetic Act (Drug Act). 2 On May 21,1979, the Board issued to Petitioner an amended citation and notice of hearing charging that Petitioner procured non-narcotic Schedule II controlled substances, including Quaalude and Percodan, for himself and others by forging several names and addresses on prescription blanks presigned by a Dr. Lumen J. Popp for other purposes. The amended citation charged that Petitioner’s actions violated Sections 5(a) (6) and 8(13) of the Pharmacy Act, 63 P.S. §390-5(a)(6) and §390-8(13), 3 and the Board’s rules and regulations at 49 Pa. Code §27.18(b) and (c). 4 It is important to note that Petitioner was charged with no violations of the Drug Act in the amended citation.

*577 The Board held a hearing on the charges contained in the amended citation and found that Petitioner’s conduct did violate the above sections of the Pharmacy Act and the Board’s regulations. In the Board’s opinion, these violations justified a revocation of Petitioner’s license.

Two issues are presented by Petitioner for our consideration: 1) whether or not the Board exceeded its authority in.revoking Petitioner’s license for charges which rise only to the level of a misdemeanor; and 2) whether or not the Board’s action was so inordinately harsh under the circumstances as to constitute abuse of discretion and/or cruel punishment.

First, Petitioner argues that although Section 5 (a)(6) of the Pharmacy Act gives the Board power to revoke or suspend licenses for violations of the Pharmacy Act or its regulations, since his conduct is prohibited by the Drug Act as well, the Board’s revocation and suspension power under the Pharmacy Act is restricted by the revocation and suspension provivisions contained in Section 23(b) of the Drug Act, 35 P.S. §780-123(b). 5

Section 23(b) of the Drug Act provides, in relevant part:

The appropriate licensing boards in the Department of State are hereby authorized to revoke or suspend the registration or license of any practitioner when such person has pleaded *578 ..guilty or nolo contendere or has been convicted of a felony under this act or any similar State or Federal law.

Petitioner concludes that because his prohibited conduct only rises to the level of misdemeanor rather than felony under both acts, 6 the Board has no authority to revoke or suspend his license.

In Duda v. State Board of Pharmacy, 38 Pa. Commonwealth Ct. 378, 393 A.2d 57 (1978), we interpreted the effect of Section 23(b) of the Drug Act on Section 5(a)(2) of the Pharmacy Act, 63 P.S. §390-5 (a)(2), which provides:

(a) The board shall have the power to revoke or suspend the license of any pharmacist upon proof satisfactory to it that:
(2) He has been found guilty, pleaded guilty or entered a plea of nolo contendere to any offense in connection with the practice of pharmacy or involving moral turpitude before any court of record of any jurisdiction;

In Duda, the Court held that those two statutory provisions were irreconcilable “in part.” Judge Rogers, writing for the Court, said

Section 23(b) of the Drug Act restricts the pow-' er of the State to impose the strictures of suspension or revocation of licenses to cases where the licensee has pleaded guilty or nolo contendere or has been convicted of a felony under the Drug Act. Section 5 of the Pharmacy Act authorizes the Board of Pharmacy to suspend or revoke the license of one who has been found *579 guilty, pleaded guilty or entered á plea of nolo contendere to any offense in connection with the practice of pharmacy. Insofar as Section 5 of the Pharmacy Act provides, as it does that the Pharmacy Board has power to suspend or revoke for an offense under the Drug Act other than one which the Drug Act says is a felony, it is irreconcilable with Section 23(b) of the Drug Act which provides that only offenses which are felonies under that Act may be punished by suspension or revocation. Which controls? Clearly Section 23(b) of the Drug Act. (Emphasis in original.)

Id. at 381, 393 A.2d at 59.’

Two subsequent decisions by this Court clearly indicate that our holding in Duda was a narrow one. In Rice v. State Board of Pharmacy, 42 Pa. Commonwealth Ct. 543, 401 A.2d 404 (1979), the petitioner pleaded guilty to charges under the Drug Act constituting misdemeanors. The Court held that the Board in that instance lacked the authority to revoke the petitioner’s license because “while the Board may suspend or revoke the license of any pharmacist for offenses other than Drug Act violations, he they felonies or misdemeanors, it may revoke or suspend a Drug Act violator’s license only when his or her actions rise to the level of a felony.” (Emphasis added.) Id. at 545, 401 A.2d at 405, citing Duda. In Carr v. State Board of Pharmacy, 48 Pa. Commonwealth Ct. 330, 409 A.2d 941 (1980), on the other hand, the Board revoked the petitioner’s pharmacist license for an offense “other than a Drug Act violation.” Petitioner in Carr was found by the Board to be in violation of Section 5 of the Pharmacy Act and the regulations at 49 Pa. Code §27.18 (c) and (d), for her conduct of selling drugs (cocaine and dexedine) without a prescription. *580 Though not at issue, the Court therein noted that “[ti]he sale of drugs without a prescription is an offense under the Pharmacy Act and does not require a felony conviction as a precedent to a license suspension or revocation, as is required under the Controlled Substance, Drug, Device and Cosmetic Act [Drug Act].’’ Carr, 48 Pa. Commonwealth Ct. at 332 n. 3, 409 A.2d at 943 n. 3.

In the instailt case, the charges against the Petitioner afe not

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Gombach v. Department, Bureau of Commissions, Elections & Legislation
692 A.2d 1127 (Commonwealth Court of Pennsylvania, 1997)
Gangewere v. Commonwealth
512 A.2d 301 (Commonwealth Court of Pennsylvania, 1986)
Drogowski v. Commonwealth
503 A.2d 104 (Commonwealth Court of Pennsylvania, 1986)
Rosenthal v. Commonwealth
457 A.2d 243 (Commonwealth Court of Pennsylvania, 1983)

Cite This Page — Counsel Stack

Bluebook (online)
432 A.2d 295, 60 Pa. Commw. 574, 1981 Pa. Commw. LEXIS 1605, Counsel Stack Legal Research, https://law.counselstack.com/opinion/moeslein-v-commonwealth-state-board-of-pharmacy-pacommwct-1981.